Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EGb761 (Ginaton) for Diabetic Retinopathy Prevention and Treatment
ChiCTR2500111450Phase 4Not yet recruiting
- Sponsor
- Shanghai General Hospital
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ginkgo biloba extract in type 2 diabetes mellitus (T2DM) and diabetic retinopathy (DR) (2 arms), sponsored by Shanghai General Hospital. Primary endpoint: Retinal and choroidal hemodynamic parameters. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
ginkgo biloba extract
03
Conditions
type 2 diabetes mellitus (T2DM)diabetic retinopathy (DR)
Beyond the preview
Go deeper on ChiCTR2500111450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500111450.